Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04163484
NCT04163484
Completed
Not Applicable

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

I.M. Sechenov First Moscow State Medical University1 site in 1 country156 target enrollmentJanuary 15, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCoronary Artery DiseaseAngina, UnstableAngina, StableSTEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MIContrast-induced NephropathyAcute Kidney Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
I.M. Sechenov First Moscow State Medical University
Enrollment
156
Locations
1
Primary Endpoint
Contrast associated acute kidney injury
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

Registry
clinicaltrials.gov
Start Date
January 15, 2019
End Date
May 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Olga Mironova

MD PhD Associate Professor

I.M. Sechenov First Moscow State Medical University

Eligibility Criteria

Inclusion Criteria

  • •Males and females aged 18-80
  • •Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI
  • •Intra-arterial injection of iodinated contrast media
  • •Informed consent

Exclusion Criteria

  • •Age less than 18
  • •Pregnancy, lactation
  • •Refuse to sign the informed consent
  • •Contraindications for PCI
  • •Other conditions affecting prognosis (oncology, liver failure etc)
  • •CKD stage 4-5
  • •Patients receiving nephrotoxic drugs

Outcomes

Primary Outcomes

Contrast associated acute kidney injury

Time Frame: 48-72 hours

Number of patients with contrast associated kidney injury after contrast exposure

Secondary Outcomes

  • Overall mortality(1 year)
  • Repeat hospitalisation(1 year)
  • Stroke(1 year)
  • New-onset dialysis(1 year)
  • Cardiovascular mortality(1 year)
  • Myocardial infarction(1 year)
  • Repeat revascularization(1 year)
  • Acute decompensation of heart failure(1 year)
  • Chronic kidney disease progression(1 year)

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Clinical Validation of the RENISCHEM L-FABP POC AssayAcute Kidney InjuryContrast-induced Nephropathy
NCT04864847Hikari Dx, Inc.450
Completed
Not Applicable
Incidence of contrast-induced acute kidney injury after cerebral endovascular procedures.
JPRN-UMIN000045673Tokyo Metropolitan Tama Medical Center200
Completed
Not Applicable
Acute Renal Injury Associated Contrast in Intensive Care Unit PatientsAcute Renal Injury
NCT01807195Yonsei University886
Recruiting
Not Applicable
Medication induced renal failure in children undergoing scan with medication injectio
CTRI/2017/03/008060Director JIPMER96
Completed
Phase 4
Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)Contrast Induced NephropathyAcute Myocardial Infarction
NCT00827788Ospedale San Donato432